Table 3 Possible risk factors associated with mortality among CM patients with DM II
Variables | Surviving patients (N = 20) | Dead patients (N = 6) | P value |
|---|---|---|---|
Age (years) | 57.95 ± 15.38 | 55.75 ± 10.61 | 0.533 |
Sex: Male (n %) | 9 (45.00%) | 3 (50.00%) | 0.829 |
Duration before confirmed diagnosis (days) | 29.85 ± 22.80 | 17.83 ± 11.05 | 0.355 |
Duration of DM II course (years) | 4.27 ± 3.67 | 4.00 ± 2.19 | 0.882 |
Poor DM II management (n %) | 6 (30.00%) | 4 (66.67%) | 0.105 |
Underlying diseases (n %) | 11 (55.00%) | 4 (66.67%) | 0.612 |
Clinical parameters | |||
 Fever (n %) | 15 (75.00%) | 6 (100%) | 0.671 |
 Headache (n %) | 19 (73.08%) | 6 (100%) | 0.419 |
 Nausea/Vomiting (n %) | 10 (50.00%) | 6 (100%) | 0.027* |
 Vision disorders (n %) | 3 (15.00%) | 1 (16.67%) | 0.921 |
 Auditory symptoms (n %) | 3 (15.00%) | 1 (16.67%) | 0.921 |
 Seizure (n %) | 2 (10.00%) | 1 (16.67%) | 0.654 |
 Conscious disturbance (n %) | 5 (25.00%) | 3 (50.00%) | 0.245 |
CSF examinations | |||
 Opening pressure (mmH2O) | 258.00 ± 99.92 | 316.67 ± 98.20 | 0.295 |
 CSF protein (mg/l) | 983.35 ± 641.03 | 1175.20 ± 411.96 | 0.268 |
 CSF glucose (mmol/l) | 2.38 ± 1.13 | 1.95 ± 0.40 | 0.882 |
 Brain images abnormalitya (n %) | 13 (65.00%) | 5 (83.33%) | 0.393 |